IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Stem Cell Transplantation
M.D. Anderson Cancer Centermonoclonal_antibodyPhase 2Dormant
BB
70/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 58/ 100
- Competitive Position
- 89/ 100
Competitive context
6 Active assets in the Stem Cell Transplantation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FILGRASTIM National Cancer Institute (NCI) | Phase 2/3 | BBB |
Thiotepa medac GmbH | Phase 2 | BB |
Evomela Institute of Hematology & Blood Diseases Hospital, China | Phase 3 | BB |
Anti-Thymoglobulin, Rabbit The First Affiliated Hospital of Soochow University | Phase 3 | BB |
PENTOSTATIN National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 | CCC |
View all 12 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →